WNT7B and glioblastoma: Notably, this suggests that the effects of WNT974+αPD1 on the myeloid compartment are not restricted to tumors with high Wnt7b expression or stem-like phenotypes but may instead represent a conserved immunomodulatory response across diverse GBM models.